Published on : 12 Nov 2025, 12:05 pm 2 min read

The Delhi High Court on Wednesday refused to pass any interim orders allowing JNTL Consumer Health, the Indian subsidiary of American healthcare giant Johnson & Johnson, to sell its stock of ORSL Electrolyte Drink.

The sale of the drink was stopped following the Food Safety and Standards Authority of India (FSSAI) directive banning the sale of beverages with misleading ORS labels. The total value of the ORSL unsold stock is stated to be nearly ₹100 crores.

A Division Bench of Chief Justice Devendra Kumar Upadhyaya and Justice Tushar Rao Gedela today rejected the interim relief application filed by JNTL in its plea challenging the FSSAI directives as well as the law mandating companies to recall the products from the market.

Th

See Full Page